Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nehprotic syndrome with glomerular mesangial IgM deposits.

Literature DB >> 347169

Nehprotic syndrome with glomerular mesangial IgM deposits.

A H Cohen, W A Border, R J Glassock.

Abstract

Entities: Disease

Mesh：

Substances：
Immunoglobulin M

Year: 1978 PMID： 347169

Source DB: PubMed Journal: Lab Invest ISSN： 0023-6837 Impact factor: 5.662

Keyword Cloud
Cited

× No keyword cloud information.

43 in total

1. Is cyclophosphamide effective in patients with IgM-positive minimal change disease?

Authors: Pavel Geier; Amani Roushdi; Sylva Skálová; Jennifer Vethamuthu; Gabrielle Weiler; Janusz Feber
Journal: Pediatr Nephrol Date: 2012-06-24 Impact factor: 3.714

2. Misapplication of Russell's name.

Authors: A Lendrum
Journal: J Clin Pathol Date: 1981-06 Impact factor: 3.411

3. A case of membranoproliferative glomerulonephritis developed over twenty years with three different findings of renal pathology.

Authors: Yoshikatsu Kaneko; Kazuhiro Yoshita; Hideyuki Kabasawa; Naofumi Imai; Yumi Ito; Mitsuhiro Ueno; Shinichi Nishi; Ichiei Narita
Journal: CEN Case Rep Date: 2012-11-09

4. Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial.

Authors: Pietro Ravani; Alberto Magnasco; Alberto Edefonti; Luisa Murer; Rossella Rossi; Luciana Ghio; Elisa Benetti; Floriana Scozzola; Andrea Pasini; Nadia Dallera; Felice Sica; Mirco Belingheri; Francesco Scolari; Gian Marco Ghiggeri
Journal: Clin J Am Soc Nephrol Date: 2011-05-12 Impact factor: 8.237

Nehprotic syndrome with glomerular mesangial IgM deposits.

1. Is cyclophosphamide effective in patients with IgM-positive minimal change disease?

2. Misapplication of Russell's name.

3. A case of membranoproliferative glomerulonephritis developed over twenty years with three different findings of renal pathology.

4. Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial.

5. Comment on: IgM nephropathy: Can we still ignore it.

6. IgM nephropathy; time to act.

7. Aberrant IgM on T cells: biomarker or pathogenic factor in childhood nephrotic syndrome?

8. Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome.

9. Clinical Significance of IgM and C3 Glomerular Deposition in Primary Focal Segmental Glomerulosclerosis.

10. Long-term outcome of heavy proteinuria in patients under 2 years of age.